Project Grant HT94252410891
Award Date
9/30/24
Completion Date
9/29/28
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Australia
Similar Awards
The federal Project Grant award of $856,523.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research to transform healthcare for military service members and the public. The award, effective September 30, 2025 through September 29, 2028, will fund research by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to investigate neurovascular and cognitive recovery from a...
This federal Project Grant award of $170,712.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research on the comparative effectiveness of exercise, cognitive behavioral therapy, and their combination for individuals with chronic musculoskeletal pain and poor sleep. The award, with a period of performance from September 30, 2024 to September 29, 2028, is funding research conducted by the University of Queensland in Australia. The...
The Department of the Army Medical Command awarded a $1.66 million Project Grant to the University of Utah's Office of Sponsored Projects under the Military Medical Research and Development program (CFDA 12.420). The three-year award will fund research into "Spreading Depolarizations' in the Network Dysfunction Leading to Post-Traumatic Headache." Through September 2021 to August 2024, the grantee will investigate medical solutions for post-traumatic headache on the battlefield and...
The federal Project Grant award of $433,126 was granted by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to The University of Texas Health Science Center at San Antonio (UTHSCSA). The funding will support a 3-year research project, from January 1, 2025 to December 31, 2027, focused on "Exploring the Role of PACAP38 in Post-Traumatic Headache". UTHSCSA, a prominent academic medical center with expertise in biomedical research and...
The Department of the Army Medical Command awarded a $2,008,900 project grant to the Veterans Medical Research Foundation of San Diego under the Military Medical Research and Development program (CFDA 12.420). The four-year project grant will fund research into combined nonpharmacological therapies for mild traumatic brain injury (mTBI)-related headaches from September 2021 through August 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
This federal Project Grant award, totaling $1,012,894.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate pain reprocessing therapy for veterans with chronic back pain. The 4-year award, with a start date of September 30, 2024, will compare the efficacy of this therapy and examine facilitators and barriers to implementation. The University of Colorado-Denver is the prime awardee, with sub-awards going to Texas...
The University of Texas Health Science Center at San Antonio (UTHSCSA) was awarded a $6,133,100 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a 4-year research project to develop and validate personalized treatment models for persistent headaches attributable to mild traumatic brain injury in U.S. military service members and veterans. The research includes specifying and validating patient-centered models...
The federal Project Grant award, ID HT94252410663, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award of $1,460,000.00, effective September 1, 2024 through August 31, 2028, supports research to investigate photobiomodulation therapy as a potential treatment strategy for post-traumatic stress disorder. The principal investigator was changed from Dr. Joseph Jordan to Dr. Xuemei Zong, and a subaward was...
This $2,699,157 federal Project Grant award from the U.S. Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research to evaluate the effectiveness of a traumatic brain injury whole blood test in improving assessment and triage for patients with mild traumatic brain injury presenting to civilian emergency departments. The University of Pittsburgh, a major public research university, is the prime awardee and will conduct this research...
This federal Project Grant award of $2,580,566, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports a randomized clinical trial to evaluate different approaches to rehabilitation for concussion. The award recipient, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., will conduct the "SYMPTOM-TARGETED APPROACH TO REHABILITATION FOR CONCUSSION (STAR-C)" study, which will...